9069 Results

Journal Article

Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials

Authors: Gustavo A. Viani, Andre G. Gouveia, Fernando K. Matsuura, Alexandre A. Jacinto, Fabio Y. Moraes

Journal Article

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours

Authors: Christina Jentsch, Ralf Bergmann, Kerstin Brüchner, Birgit Mosch, Ala Yaromina, Mechthild Krause, Daniel Zips, Esther G.C. Troost, Steffen Löck, Jörg Kotzerke, Jörg Steinbach, Howard Thames, Michael Baumann, Bettina Beuthien-Baumann

Journal Article

Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours

Authors: L. Hoffmann, G.F. Persson, L. Nygård, T.B. Nielsen, S. Borrisova, F. Gaard-Petersen, M. Josipovic, A.A. Khalil, R. Kjeldsen, M.M. Knap, C. Kristiansen, D.S. Møller, W. Ottosson, H. Sand, R. Thing, M. Pøhl, T. Schytte

Congress Abstract

Multicenter end-to-end test for lung SBRT treatments

Authors: Pallotta|, Stefania(1)*[stefania.pallotta@unifi.it];Marrazzo|, Livia(2);Calusi|, Silvia(1);Talamonti|, Cinzia(1);Russo|, Serenella(3);Esposito|, Marco(3);Fiandra|, Christian(4);Giglioli|, Francesca Romana(5);Pimpinella |, Maria(6);De Coste|, Vanessa(6);Stravato|, Antonella(7);Stasi|, Michele(8);Mancosu|, Pietro(7);Lisci|, Riccardo(9);
(1)Azienda Ospedaliero Universitaria Careggi - University of Florence, Department of Biomedical Experimental and Clinical Sciences "Mario Serio", Florence, Italy;(2)AOU Careggi, Medical Physics Unit, Florence, Italy;(3)Firenze Azienda Sanitaria USL Toscana Centro, Fisica Sanitaria, Florence, Italy;(4)University of Turin, Oncology Department, Turin, Italy;(5)AOU Città della Salute e della Scienza di Torino, Medical Physics Unit, Turin, Italy;(6)ENEA-INMRI, National Institute of Ionizing Radiation Metrology-, Rome, Italy;(7)Humanitas Cancer Centre, Radiotherapy, Rozzano MI, Italy;(8)AO Ordine Mauriziano, Health Physics, Turin, Italy;(9)University of Florence, Department of Agricultural- Food and Forestry System, Florence, Italy;
Show Affiliations

Congress Abstract

Cardiopulmonary Sparing During Breast RT with Personalized Breast Holder and Proton Beam Therapy

Authors: WANG , Renyi(1)*[144012@h.tmu.edu.tw];Chen , Tung Ho(1);Chung , Meng Yun(2);Tien , Der Chi(2);Tseng , Kuo Hsiung(2);Chiou , Jeng Fong(1,3,4);Lu , Long Sheng(1,5);
(1)Taipei Medical University Hospital, Radiation Oncology, Taipei, Taiwan;(2)National Taipei University of Technology, Electrical Engineering, Taipei, Taiwan;(3)Taipei Medical University, Radiology- School of Medicine- College of Medicine, Taipei, Taiwan;(4)Taipei Medical University, Taipei Cancer Center, Taipei, Taiwan;(5)Taipei Medical University, Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei, Taiwan;
Show Affiliations

Journal Article

Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma

Authors: Alexandra N. De Leo, Adam L. Holtzman, Meng Wei Ho, Christopher G. Morris, Michael S. Rutenberg, Ronny L. Rotondo, James E. Bates, Daniel J. Indelicato, Dinesh Rao, Mohammad ASA Hasan, William M. Mendenhall

Congress Abstract

How to achieve the sharpest dose fall-off for hypo-fractionated radiosurgery of large brain lesions?

Authors:

Tomi Nano1, Olivier Morin1, Benjamin Ziemer1, David Raleigh1, Lauren Boreta1, Jean Nakamura1, Shannon Fogh1, Penny Sneed1, Shawn Harvey-Jumper2, Phillip Theodosopoulos2, Steve Braunstein1, Lijun Ma1

1University of California, San Francisco (UCSF), Radiation Oncology, San Francisco, USA; 2University of California, San Francisco (UCSF), Neurological Surgery, San Francisco, USA

Show Affiliations

Congress Abstract

Phase I/II trial of ultra-APBI on early breast cancer (4f-APBI): Initial feasibility results.

Authors: Gimeno Morales|, Marta(1)*[mgmorales@unav.es];Martínez-Monge|, Rafael(1);Martínez-Regeira|, Fernando(2);Rodríguez-Spiteri|, Natalia(2);Olartecoechea|, Begoña(3);Ramos|, Luis(4);Pina|, Luis(5);Elizalde|, Arlette(5);Idoate|, Miguel(6);Abengozar|, Marta(6);Aristu|, Javier(7);Moreno|, Marta(1);Arbea|, Leire(1);Aramendía|, Jose Manuel(8);Santisteban|, Marta(8);Jablonska|, Paola(1);García-Consuegra|, Alejandro(1);Fardique|, Sara(1);Cambeiro|, Mauricio(9);
(1)Clinica Universidad de Navarra, Radiation Oncology, Pamplona, Spain;(2)Clinica Universidad de Navarra, General Surgery, Pamplona, Spain;(3)Clinica Universidad de Navarra, Gynaecology, Pamplona, Spain;(4)Clinica Universidad de Navarra, Physics, Pamplona, Spain;(5)Clinica Universidad de Navarra, Radiology, Pamplona, Spain;(6)Clinica Universidad de Navarra, Pathology, Pamplona, Spain;(7)Clinica Universidad de Navarra, Radiation Oncolgy, Madrid, Spain;(8)Clinica Universidad de Navarra, Oncology, Pamplona, Spain;(9)Clinica Universidad de Navarra, Radiation Oncology, Madrid, Spain;
Show Affiliations

Congress Abstract

ALBI & IBI score could help in deciding for or against a radioablative therapy in patients with HCC.

Authors:

Peter Hass1, Thomas B. Brunner1, Ahmed Gawish1, Dominik Ott1

1University Hospital Magdeburg, Radiooncology, Magdeburg, Germany

Show Affiliations

Congress Abstract

SCRT and chemotherapy vs LCRT for unresectable rectal cancers. A propensity matched-pair analysis

Authors: Engineer|, Reena(1)*[reena_engineer@rediffmail.com];Saklani|, Avanish(2);D'souza|, Ashwin(2);Mokal|, Smruti(3);Dhyani|, Aruj(1);Chopra|, Supriya(1);
(1)Tata Memorial Hospital, Radiation Oncology, Mumbai, India;(2)Tata Memorial Hospital, Surgical Oncology, Mumbai, India;(3)Tata Memorial Hospital, Statistics, Mumbai, India;
Show Affiliations
*:*